Categories: India

BRIEF-Allarity Therapeutics Expands Phase 2 Stenoparib Trial To Three Ovarian Cancer Patient Cohorts

Recent Posts

BRIEF-Sephaku Holdings Posts HEPS For Six Months Ended Sept 30 2026 At 15.49 Cents

Nov 16 (Reuters) - Sephaku Holdings Limited: * JSE: SEP - UNAUDITED CONDENSED CONSOLIDATED INTERIM…

5 minutes ago

Analysis-Nvidia's AI financing machine may survive Huang, but with less risk appetite

By Saeed Azhar NEW YORK, Nov 16 (Reuters) - Nvidia's $500 billion AI financing platform…

7 minutes ago

Jordan and Iraq block Telegram app over national security concerns

Nov 16 (Reuters) - Jordanian and Iraqi authorities said on Monday they will block the…

8 minutes ago

Spain's right retains firm poll lead despite Socialist gains

By Mireia Merino MADRID, Nov 16 (Reuters) - Spain's conservative People's Party (PP) and far-right…

12 minutes ago